Max Robotics — Global Service Robot Directory + US Certification

About

Da Li is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for colorectal cancer treatment. His most impactful work compares robotic versus laparoscopic surgery for middle and low rectal cancer, addressing a critical gap in long-term oncological outcomes. In his landmark 2025 study, which has already garnered 79 citations, Li demonstrated that robotic surgery achieves comparable 3-year locoregional recurrence rates to conventional laparoscopy, providing essential evidence for the safety and efficacy of robotic approaches. This contribution has helped guide clinical decision-making for surgeons worldwide, particularly as robotic systems become more prevalent. Beyond this core study, Li’s research portfolio spans surgical innovation, cancer survivorship, and quality-of-life outcomes, reflecting his commitment to both technical excellence and patient-centered care. His work is widely cited by peers and has influenced international treatment guidelines. For students and researchers, Li exemplifies how rigorous comparative effectiveness research can translate into meaningful improvements in surgical practice and patient outcomes.